At $1 AGH would be valued at roughly $200m market cap (currently $100m at $0.50).
So yeah this is certainly achievable IMO. This time last year many medicinal cannabis companies were flying high (pun intended) on market caps of multiples of this. When CAN hit $4.50 briefly that was a valuation of $640m! Obviously this was all based on euphoria and other factors, but it shows that its possible.
If Althea continues to show strong growth in Australia in establishing themselves as patient access leader and London expansion takes off then it certainly justifies $1+. (Again, IMO).
Rebound time, page-317
-
- There are more pages in this discussion • 278 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.15M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 508 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 33310 | 1 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| AGH (ASX) Chart |
Day chart unavailable